Cargando…

[(99m)Tc]Tc-PSMA-T4—Novel SPECT Tracer for Metastatic PCa: From Bench to Clinic

Despite significant advances in nuclear medicine for diagnosing and treating prostate cancer (PCa), research into new ligands with increasingly better biological properties is still ongoing. Prostate-specific membrane antigen (PSMA) ligands show great potential as radioisotope carriers for the diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurin, Michał, Wyczółkowska, Monika, Sawicka, Agnieszka, Sikora, Arkadiusz Eugeniusz, Karczmarczyk, Urszula, Janota, Barbara, Radzik, Marcin, Kłudkiewicz, Dominik, Pijarowska-Kruszyna, Justyna, Jaroń, Antoni, Wojdowska, Wioletta, Garnuszek, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658561/
https://www.ncbi.nlm.nih.gov/pubmed/36364046
http://dx.doi.org/10.3390/molecules27217216